Design and Managed by
Compounded Semaglutide
The high cost and limited availability of GLP-1 medications have made it difficult for many patients to begin or maintain their therapy without interruption. These medications have significant potential to reduce A1C levels and aid in weight management.
To address this need, Ewing Pharmacy’s compounding lab has developed a GLP-1 suspension. Our *compounded semaglutide is designed for sublingual (under the tongue) administration for patients seeking GLP-1 therapy.
Please note that a prescription from a healthcare provider is required for this compound. For more information, please contact us.
*Compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality.
What is Semaglutide?
Semaglutide is a medication that falls under the class of glucagon-like peptide-1 (GLP-1) receptor agonists. These medications mimic the GLP-1 hormone, which is naturally released in the gut in response to eating.
GLP-1 medications have gained widespread attention for their effectiveness in managing blood sugar levels and supporting weight loss. Among these, semaglutide and tirzepatide are the most commonly prescribed.
Semaglutide at work
GLP-1 send signals to the brain to regulate appetite and food intake. In certain amounts, GLP-1s may suppress appetite, manage blood sugar, control blood sugar spikes, and reduce cravings. When used in conjunction with diet and exercise, they may help patients lose weight.
Why Choose our Semaglutide Compound?
Availability
Supply chain shortages of traditional GLP-1s can make them difficult to obtain regularly. Our options are readily available to ensure uninterrupted therapy for patients with specific medical need(e.g., an allergy to an inactive ingredient in the commercial version)
Affordability
Many insurances do not cover traditional GLP-1s, making the out-of-pocket costs unaffordable for most people. We offer more affordable pricing compared to other options on the market.
Credibility
Our sublingual product is made using FDA-registered sources for the active ingredient, and our injectable compound is sourced from an FDA-registered facility, ensuring high quality and reliability.
Medical Necessity Notice:
In accordance with federal law, our compounded GLP-1 medications are prepared exclusively for individual patients with a specific medical need (e.g., an allergy to inactive ingredients in commercial versions or inability to use standard dosage forms) and require a patient-specific prescription from a licensed provider.
FAQs
How is the sublingual suspension administered?
It is placed under the tongue and held for at least two minutes before swallowing to allow for optimal absorption. Avoid eating or drinking for 30 minutes after dosing.
Does it require refrigeration?
Yes, like all GLP-1 therapies, our compounds should be stored in the refrigerator to maintain stability and potency.
How long does it take to see results?
Most patients begin to see steady-state results within 8 to 12 weeks of consistent therapy alongside diet and exercise.
Are there side effects?
Common side effects can include mild nausea, indigestion, or changes in bowel habits. Our pharmacists provide a full consultation to help you manage these.
Sublingual vs. Injectable?
Feature,Sublingual Suspension,Injectable Compound
Administration,Daily (Under the tongue),Weekly (Subcutaneous)
Best For,Patients with needle phobia,Patients preferring weekly dosing
Absorption,Bypasses the digestive tract,Directly into fatty tissue
Storage,Must be refrigerated,Must be refrigerated